WGRX

MKT CAP:$9M

Wellgistics Health, Inc.

Market Cap

$9M

Healthcare·Medical - Distribution·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$0.13-$0.30 (-69.09%)

Apr 22, 2026

Company Details

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals...

CEO

Prashant Patel

IPO Date

Feb 25, 2025

Website

www.wellgisticshealth.com

Key Metrics TTM

Revenue

$23M

— YoY

Net Income

-$101M

EPS (Diluted)

-$1.46

Free Cash Flow

-$11M

Revenue / Share

$0.33

Gross Margin

-41.3%

Operating Margin

-347.9%

Net Margin

-433.9%

FCF Margin

-46.5%

P/S

0.4x

P/E

—

Earnings Reports

Q1 2026

May 11, 2026

PENDING

FY 2025

Mar 20, 2026

$23M+28.7%EPS -$1.43

Q4 2025

Mar 20, 2026

$2MEPS -$0.27

Q3 2025

Nov 19, 2025

$3MEPS -$0.46

Q2 2025

Aug 19, 2025

$8MEPS -$0.11

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 23	$0	$0	-$428.8K
Q3 23	$0	$0	-$903.3K
Q1 25	$11M	$692.6K	-$31M
Q2 25	$8M	$505.8K	-$6M
Q3 25	$3M	-$571.8K	-$32M
Q4 25	$2M	-$10M	-$13M

Valuation

Quarter	P/S	P/E
Q2 23	—	—
Q3 23	—	—
Q1 25	—	—
Q2 25	2.7x	—
Q3 25	2.7x	—
Q4 25	1.2x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 23	$112.9K	$112.9K
Q1 25	-$1M	-$2M
Q2 25	-$2M	-$2M
Q3 25	-$1M	-$730.3K
Q4 25	-$6M	-$6M

Capital Expenditures

Quarter	CapEx
Q3 23	$0
Q1 25	$273.1K
Q2 25	$131.9K
Q3 25	$405.1K
Q4 25	$3

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 25	—	+7960.7%
Q4 25	—	+1501.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 23	$0	—
Q1 25	$28M	255.7%
Q2 25	$935.2K	12.0%
Q3 25	$26M	854.0%
Q4 25	$355.7K	21.3%

OpEx Breakdown

Quarter	G&A	S&M	SG&A
Q2 23	—	—	$428.8K
Q3 23	—	—	$903.3K
Q1 25	$31M	$65.2K	—
Q2 25	$5M	$343.4K	—
Q3 25	$30M	$803.7K	—
Q4 25	$4M	$12.2K	—

Revenue Segments

Quarter	Product
Q1 25	$11M
Q2 25	$8M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$1.4K	$0	$1.4K
Q1 24	$917.1K	$0	$917.1K
Q2 24	$2M	$0	$2M
Q3 24	$793.1K	$0	$793.1K
Q4 24	$1M	$0	$1M
Q1 25	$3M	$0	$3M
Q2 25	$419.9K	$0	$419.9K
Q3 25	$4M	$0	$4M
Q4 25	$42.6K	$0	$42.6K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 23	52M	—	—
Q3 23	52M	0.0%	—
Q1 25	52M	-0.1%	—
Q2 25	62M	+19.0%	—
Q3 25	74M	+20.4%	+43.2%
Q4 25	71M	-4.6%	+36.7%

Shares Outstanding